About Wiesel Pharmaceutical
Wiesel Pharmaceutical is a Healthcare company. Pharmaceutical marketing and product distribution of tablets and capsules. Its Indian entity Wiesel Pharmaceutical Private Limited reported revenue of ₹94.9 Lakh. Wiesel Pharmaceutical offers products and services including Hepta Gold Tab and Bitazn Capsule. Its focus areas include Pharmaceuticals, Drug Manufacturing, Tablets and Capsules and Medicinal Products.
Company details
Wiesel Pharmaceutical Private Limited is identified as a company engaged in pharmaceutical marketing, where products like Hepta Gold Tab, Bitazn Capsule, and Wielcored Tab are offered for distribution. Its operations are centered on promoting these items in the healthcare sector, ensuring they are made available through established channels. The entity is structured as a private limited company, with a focus on handling medicinal tablets and capsules that are utilized in various medical contexts. Activities are conducted in a manner that supports industry standards without promotional intent.
- SectorsHealthcare
- Legal Name Wiesel Pharmaceutical Private Limited
- Date of Incorporation 23 Apr, 2018
- Jurisdiction Lucknow, Uttar Pradesh, India
- Indian entity revenue₹94.9 Lakh
FY 2024 · +19% YoY
- Indian entity net profit₹1.5 Lakh
FY 2024 · 2% margin
- Indian entity EBITDA₹2.3 Lakh
FY 2024 · 2% margin
Associated legal entities of Wiesel Pharmaceutical
Wiesel Pharmaceutical operates through Wiesel Pharmaceutical Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Wiesel Pharmaceutical Private Limited CIN U24304UP2018PTC103509 | Active | 23 Apr 2018 | Lucknow, Uttar Pradesh | ₹0.9 Cr | 2 | View details |
Products & Services of Wiesel Pharmaceutical
Wiesel Pharmaceutical offers a comprehensive portfolio of products and services, including Hepta Gold Tab and Bitazn Capsule.
Tablets are marketed for medical applications
Capsules are distributed for pharmaceutical use
Board of directors of Wiesel Pharmaceutical Private Limited (Wiesel Pharmaceutical)
Wiesel Pharmaceutical Private Limited is the primary company behind Wiesel Pharmaceutical. The board of Wiesel Pharmaceutical Private Limited currently have 2 directors; the longest-serving is Nitin Kumar Chaudhary, appointed in 2018. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Nitin Kumar Chaudhary DIN 08117324 | Director | 23 Apr 2018 | 8 yrs 6 mo | Wiesel Pharmaceutical Private Limited |
| Shailesh Kumar Chaudhary DIN 03091779 | Director | 05 Feb 2019 | 7 yrs 8 mo | Wiesel Pharmaceutical Private Limited |
Financials of Wiesel Pharmaceutical
Figures of Wiesel Pharmaceutical Private Limited, the primary company behind Wiesel Pharmaceutical, for FY 2024. Revenue was ₹94.9 Lakh (+19% year on year). Net profit was ₹1.5 Lakh (2% margin). EBITDA was ₹2.3 Lakh (2% margin). Revenue has grown at a compounded annual rate of +35% over three years.
- ₹94.9 LakhRevenue · FY 2024 · +19% YoY
- ₹1.5 LakhNet profit · 2% margin
- ₹2.3 LakhEBITDA · 2% margin
- ₹5 LakhPaid-up capital
- +35%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Wiesel Pharmaceutical Private Limited are on its company page.
Detailed financial statements for Wiesel Pharmaceutical
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Wiesel Pharmaceutical
The primary company behind Wiesel Pharmaceutical, Wiesel Pharmaceutical Private Limited, reported revenue of ₹94.9 Lakh for FY 2024, up 19% year on year.
Wiesel Pharmaceutical Private Limited is identified as a company engaged in pharmaceutical marketing, where products like Hepta Gold Tab, Bitazn Capsule, and Wielcored Tab are offered for distribution. Its operations are centered on promoting these items in the healthcare sector, ensuring they are made available through established channels. The entity is structured as a private limited company, with a focus on handling medicinal tablets and capsules that are utilized in various medical contexts. Activities are conducted in a manner that supports industry standards without promotional intent.
Wiesel Pharmaceutical offers Hepta Gold Tab and Bitazn Capsule.
Wiesel Pharmaceutical operates through Wiesel Pharmaceutical Private Limited.
The legal entities of Wiesel Pharmaceutical currently have 2 directors, including Shailesh Kumar Chaudhary, Nitin Kumar Chaudhary.